Back
Xcel Energy Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
58
XEL
Xcel Energy
Last Price:
$66.72
Seasonality Move:
0.67%
Sell
35
ASND
Ascendis Pharma AS
Last Price:
$128.13
Seasonality Move:
6.98%
Buy
58
Xcel Energy (XEL)
is a Buy
Is Xcel Energy a Buy, Sell or Hold?
-
The current Xcel Energy [XEL] share price is $66.72. The Score for XEL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
XEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XEL Stock Price Chart
What is Xcel Energy's stock price today?
-
The Xcel Energy share price today is $66.72The current trend is relatively stagnant and XEL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $128.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
XEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.82 | Sell |
Relative Strength Index (14 RSI): | 50.3 | Buy |
Chaikin Money Flow: | 2115789 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.25 - 68.21) | Sell |
Bollinger Bands (100): | (63.06 - 68.88) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | -281370 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.04 - 139.32) | Sell |
Bollinger Bands (100): | (124.47 - 141.31) | Sell |
XEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.12 | Buy |
20-day SMA: | 66.37 | Buy |
50-day SMA: | 68.24 | Sell |
200-day SMA: | 60.64 | Buy |
8-day EMA: | 65.62 | Buy |
20-day EMA: | 66.33 | Buy |
50-day EMA: | 66.82 | Sell |
200-day EMA: | 63 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.64 | Sell |
20-day SMA: | 136.01 | Sell |
50-day SMA: | 132.35 | Sell |
200-day SMA: | 134.15 | Sell |
8-day EMA: | 132.62 | Sell |
20-day EMA: | 134.21 | Sell |
50-day EMA: | 133.61 | Sell |
200-day EMA: | 131.63 | Sell |
Xcel Energy Earnings Growth & XEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.31 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.31 per share, and an increase next year of $5.63 per share.
Xcel Energy Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |